Zacks: Analysts Anticipate Nu Skin Enterprises, Inc. (NYSE:NUS) to Post $0.73 EPS

Analysts predict that Nu Skin Enterprises, Inc. (NYSE:NUSGet Rating) will post earnings per share of $0.73 for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Nu Skin Enterprises’ earnings. The highest EPS estimate is $0.75 and the lowest is $0.71. Nu Skin Enterprises posted earnings per share of $0.91 during the same quarter last year, which would indicate a negative year-over-year growth rate of 19.8%. The company is scheduled to report its next earnings results after the market closes on Monday, January 1st.

According to Zacks, analysts expect that Nu Skin Enterprises will report full year earnings of $4.29 per share for the current year, with EPS estimates ranging from $4.22 to $4.38. For the next fiscal year, analysts forecast that the company will report earnings of $4.56 per share, with EPS estimates ranging from $4.54 to $4.60. Zacks Investment Research’s EPS averages are an average based on a survey of research analysts that follow Nu Skin Enterprises.

Nu Skin Enterprises (NYSE:NUSGet Rating) last posted its quarterly earnings results on Wednesday, February 16th. The company reported $1.11 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.95 by $0.16. Nu Skin Enterprises had a net margin of 5.46% and a return on equity of 23.39%. The company had revenue of $673.44 million during the quarter, compared to the consensus estimate of $655.93 million. During the same period last year, the firm earned $1.40 EPS. The company’s revenue for the quarter was down 10.0% on a year-over-year basis.

A number of equities analysts have weighed in on NUS shares. TheStreet lowered shares of Nu Skin Enterprises from a “b” rating to a “c+” rating in a report on Friday, February 18th. Jefferies Financial Group lifted their target price on shares of Nu Skin Enterprises from $61.00 to $75.00 in a report on Thursday, February 17th. StockNews.com began coverage on shares of Nu Skin Enterprises in a report on Thursday, March 31st. They issued a “hold” rating on the stock. DA Davidson boosted their target price on shares of Nu Skin Enterprises from $47.00 to $50.00 and gave the stock a “neutral” rating in a research report on Thursday, February 17th. Finally, Zacks Investment Research raised shares of Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $57.00 target price for the company in a research report on Tuesday, March 29th. Four investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $61.17.

NUS stock traded down $2.17 during midday trading on Friday, hitting $45.33. The stock had a trading volume of 826,850 shares, compared to its average volume of 665,307. The firm has a market cap of $2.26 billion, a PE ratio of 15.91 and a beta of 1.25. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.65 and a quick ratio of 0.89. Nu Skin Enterprises has a 12-month low of $39.40 and a 12-month high of $62.70. The company’s 50-day moving average price is $48.34 and its 200 day moving average price is $47.43.

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 9th. Investors of record on Monday, February 28th were given a $0.385 dividend. This represents a $1.54 annualized dividend and a dividend yield of 3.40%. The ex-dividend date was Friday, February 25th. This is an increase from Nu Skin Enterprises’s previous quarterly dividend of $0.38. Nu Skin Enterprises’s dividend payout ratio is 54.04%.

In related news, Director Andrew D. Lipman sold 1,000 shares of the company’s stock in a transaction on Tuesday, February 22nd. The shares were sold at an average price of $53.27, for a total transaction of $53,270.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Ryan S. Napierski sold 25,000 shares of the company’s stock in a transaction on Friday, February 25th. The stock was sold at an average price of $47.40, for a total transaction of $1,185,000.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 29,000 shares of company stock worth $1,383,890. Company insiders own 4.00% of the company’s stock.

Several institutional investors have recently made changes to their positions in the stock. TCI Wealth Advisors Inc. increased its position in Nu Skin Enterprises by 66.6% in the 4th quarter. TCI Wealth Advisors Inc. now owns 758 shares of the company’s stock valued at $38,000 after acquiring an additional 303 shares in the last quarter. Covestor Ltd bought a new position in shares of Nu Skin Enterprises in the 4th quarter valued at about $48,000. Quadrant Capital Group LLC grew its holdings in Nu Skin Enterprises by 47.1% during the fourth quarter. Quadrant Capital Group LLC now owns 1,068 shares of the company’s stock valued at $54,000 after purchasing an additional 342 shares during the period. JJJ Advisors Inc. grew its holdings in Nu Skin Enterprises by 216.9% during the fourth quarter. JJJ Advisors Inc. now owns 1,870 shares of the company’s stock valued at $95,000 after purchasing an additional 1,280 shares during the period. Finally, Gladius Capital Management LP acquired a new position in Nu Skin Enterprises during the fourth quarter valued at approximately $98,000. Institutional investors and hedge funds own 80.57% of the company’s stock.

About Nu Skin Enterprises (Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

Featured Articles

Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.